PeptiDream Inc (PPTDF)
17.00
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
PeptiDream Total Liabilities (Quarterly): 230.61M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 230.61M |
March 31, 2024 | 195.91M |
December 31, 2023 | 206.45M |
September 30, 2023 | 191.73M |
June 30, 2023 | 184.28M |
March 31, 2023 | 209.87M |
December 31, 2022 | 242.72M |
September 30, 2022 | 185.41M |
June 30, 2022 | 198.81M |
March 31, 2022 | 224.73M |
December 31, 2021 | 14.64M |
September 30, 2021 | 28.00M |
June 30, 2021 | 19.16M |
March 31, 2021 | 21.78M |
December 31, 2020 | 48.96M |
September 30, 2020 | 15.34M |
June 30, 2020 | 19.98M |
March 31, 2020 | 11.38M |
September 30, 2019 | 13.13M |
June 30, 2019 | 24.01M |
March 31, 2019 | 10.80M |
December 31, 2018 | 8.42M |
Date | Value |
---|---|
September 30, 2018 | 9.438M |
June 30, 2018 | 16.23M |
March 31, 2018 | 6.530M |
December 31, 2017 | 6.001M |
September 30, 2017 | 8.256M |
June 30, 2017 | 12.92M |
March 31, 2017 | 5.297M |
December 31, 2016 | 5.522M |
September 30, 2016 | 7.556M |
June 30, 2016 | 16.67M |
March 31, 2016 | 11.05M |
December 31, 2015 | 3.167M |
September 30, 2015 | 1.353M |
June 30, 2015 | 6.732M |
March 31, 2015 | 0.9194M |
December 31, 2014 | 0.8412M |
September 30, 2014 | 0.8959M |
June 30, 2014 | 1.342M |
March 31, 2014 | 1.348M |
December 31, 2013 | 1.542M |
September 30, 2013 | 1.086M |
June 30, 2013 | 2.334M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.38M
Minimum
Mar 2020
242.72M
Maximum
Dec 2022
124.99M
Average
184.84M
Median
Total Liabilities (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 53.58B |
Nxera Pharma Co Ltd | 543.75M |
Healios KK | 90.39M |
AnGes Inc | 13.66M |
SanBio Co Ltd | 13.01M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 595.81M |
Shareholders Equity (Quarterly) | 365.20M |
Debt to Equity Ratio | 0.3561 |
Current Ratio | 3.385 |
Net Debt Paydown Yield | 0.22% |